NAK, D. Et Al. 2022. The Role of <sup>18</sup>F-FLT PET/CT in Assessing Early Response to Transarterial Radioembolization and Chemoembolization in Patients with Primary and Metastatic Liver Tumors. Molecular Imaging and Radionuclide Therapy , vol.31 , 207-215.

NAK, D., KÜÇÜK, N. Ö., ÇELEBİOĞLU, E. C., BİLGİÇ, M. S., HAYME, S., & KIR, K. M., (2022). The Role of <sup>18</sup>F-FLT PET/CT in Assessing Early Response to Transarterial Radioembolization and Chemoembolization in Patients with Primary and Metastatic Liver Tumors. Molecular Imaging and Radionuclide Therapy , vol.31, 207-215.

NAK, DEMET Et Al. "The Role of <sup>18</sup>F-FLT PET/CT in Assessing Early Response to Transarterial Radioembolization and Chemoembolization in Patients with Primary and Metastatic Liver Tumors," Molecular Imaging and Radionuclide Therapy , vol.31, 207-215, 2022

NAK, DEMET Et Al. "The Role of <sup>18</sup>F-FLT PET/CT in Assessing Early Response to Transarterial Radioembolization and Chemoembolization in Patients with Primary and Metastatic Liver Tumors." Molecular Imaging and Radionuclide Therapy , vol.31, pp.207-215, 2022

NAK, D. Et Al. (2022) . "The Role of <sup>18</sup>F-FLT PET/CT in Assessing Early Response to Transarterial Radioembolization and Chemoembolization in Patients with Primary and Metastatic Liver Tumors." Molecular Imaging and Radionuclide Therapy , vol.31, pp.207-215.

@article{article, author={DEMET NAK Et Al. }, title={The Role of <sup>18</sup>F-FLT PET/CT in Assessing Early Response to Transarterial Radioembolization and Chemoembolization in Patients with Primary and Metastatic Liver Tumors}, journal={Molecular Imaging and Radionuclide Therapy}, year=2022, pages={207-215} }